Macquarie Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Macquarie Group’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-457,565	Closed	-$12.6M	–	2692
2021 Q2	$12.6M	Buy	457,565 +460	+0.1%	+$9.04K	0.01%	884
2021 Q1	$7.54M	Sell	457,105 -247	-0.1%	-$5.63K	0.01%	804
2020 Q4	$8.43M	Buy	457,352 +456,300	+43,375%	+$8.17M	0.01%	757
2020 Q3	$14K	Hold	1,052	–	–	﹤0.01%	2236
2020 Q2	$19K	Buy	+1,052	New	+$15.9K	﹤0.01%	2188

Macquarie Group's TBIO Position: Q3 2021 in Review

Macquarie Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 457,565 shares — an estimated $12.6M sold.

Macquarie Group first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $12.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Macquarie Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Macquarie Group sold 457,565 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $12.6M.
Macquarie Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Macquarie Group's Translate Bio, Inc. Common Stock position peaked at $12.6M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Macquarie Group's 13F filing for Q3 2021, filed 12 Nov 2021.